PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
6 hedge funds and large institutions have $130K invested in PDL BioPharma, Inc. in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ATC
1
Argent Trust Co
Nashville,
Tennessee
|
$102K |
| 2 |
2
RhumbLine Advisers
Boston,
Massachusetts
|
$1.51K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ATC
1
Argent Trust Co
Nashville,
Tennessee
| $102K | 41,405 | +41,405 | New |
|
|
DT
2
Diversified Trust
Memphis,
Tennessee
| $26.5K | 11,029 | – | – |
|
|
3
RhumbLine Advisers
Boston,
Massachusetts
| $1.51K | 612 | +612 | New |
|
|
HW
4
Hancock Whitney
Gulfport,
Mississippi
| $0 | 128,396 | -41,405 | -24% |
|
|
WIM
5
Westside Investment Management
Santa Monica,
California
| $0 | 500 | – | – |
|
|
AA
6
Ancora Advisors
Cleveland,
Ohio
| $0 | 4,948 | – | – |
|
|
FGAM
7
Financial Gravity Asset Management
Lakeway,
Texas
| – | – | – | – |
|